984
Acute Inhibition of Mitochondrial Function by Efavirenz Induces Changes in Cellular Lipid Metabolism
A Blas-Garcia, M Rocha, F Baixauli, A Alvarez, V Victor, and Juan Esplugues*
Univ of Valencia and CIBEREHD, Spain
Background: Recent evidence suggests that the NNRTI
efavirenz (EFV) contributes to changes in lipid and body fat composition
implicated in lipoatrophy, but the mechanisms responsible are unknown. We have
evaluated in vitro the effects of EFV on mitochondrial respiration and cellular
lipid metabolism.
Methods: O2 consumption was measured with
a Clark-type O2 electrode in non-HIV infected Hep3B cells. Following
incubation (1 hour) with EFV (10, 25, or 50 µM) intracellular adenosine
triphosphate (ATP) was measured by fluorescence. Western blotting was used to
evaluate AMP-activated protein kinase (AMPk), the enzyme responsible for
changes in cellular energetics following the metabolic stress induced by ATP
depletion. The activity of the enzyme responsible for the entry of fatty acids
in the mitochondria, carnityl palmitoyl transferase 1 (CPT-1) was analyzed
spectrophotometrically. To reproduce inflammatory conditions, some experiments
were performed in cells incubated with tumor necrosis factor (TNF) -α (25
ng/mL). Data (n ≥3) were analyzed by one-way ANOVA (p value vs
control <0.05 *, <0.01 **, <0.001 ***).
Results: EFV induced an rapid, significant, and
dose-dependent inhibition of mitochondrial O2 consumption (percentage
reduction vs control; EFV 10 µM 26.5±5.7%***, 25µM 50.6±8.1***, 50 µM 54.7±1.4***),
which was accompanied by a reduction of intracellular ATP (control 17±2.4 nM
ATP/mg protein; EFV 10 µM 13.7±2.9%, 25 µM 9.4±2*, 50 µM 4.8±1**) and
augmentation in activated AMPK (percentage of control, EFV 10 µM 117.6±31%,
25µM 173.6±37.2, 50 µM 316.7±93.1). This was followed by an increment in
activated CPT-1 (percentage of control, EFV 10 µM 112.1±8%, 25 µM 268.3±52.5**,
50 µM 288.8±28.6**). In cells pre-treated with TNF-α, the effect on ATP
disminution was more pronounced (control 13.2±1 nM ATP/mg protein, EFV 10 µM
10±1.6, TNF-α 9±1.2, EFV 10 µM+TNF-α 6.7±0.8*).
Conclusions: Our results show that clinically used
concentrations of EFV produce an immediate decrease of mitochondrial
respiration and intracellular ATP levels. This effect seems to be the
consequence of acute interference with mitchondrial functions, since it is too
rapid to result from inhibition of mtDNA replication. This metabolic stress
leads to activation of the AMPk signalling pathways and promotes lipid
catabolism, as evident by the activation of CPT-1. Simulation of inflammatory
conditions with TNF-α, exacerbates the changes produced by EFV. These
mechanisms could be involved in lipid alterations present in lipoathrophy.
|